Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation
Clinical trial NCT01243489 · COMPLETED
Trial details
- NCT number
- NCT01243489
- Sponsor
- Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-06-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.